ITI Pharma and Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹208 Cr | ₹1208 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Meeta Shetty |
ISIN Code | INF00XX01BL5 | INF277K016A9 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -4.64% | -4.03% |
6 Month | 0.65% | -1.31% |
1 Year | 18.74% | 18.56% |
3 Year | 18.31% | 19.65% |
5 Year | - | 24.32% |
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | - | - |
1 Year | 15.23% | 14.12% |
3 Year | 26.81% | 28.17% |
5 Year | - | 22.79% |
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 24.79% | 7.82% |
3 Year | 19.26% | 17.79% |
5 Year | - | 14.55% |
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 14.52% | 14.23% |
Sharp | - | 0.74% |
Beta | - | 0.9% |
Alpha | - | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts GuidanceScheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Rohan Korde | Meeta Shetty |
Total AUM | ₹4626 Cr | ₹17847 Cr |
Fund Manage | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.8 | 5.39 |
Large Cap | 38.11 | 40.33 |
Mid Cap | 26.43 | 30.82 |
Small Cap | 33.66 | 23.46 |
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.8 | 5.39 |
Pharmaceuticals & Biotechnology | 77 | 76.28 |
Healthcare Services | 18.01 | 14.31 |
Chemicals & Petrochemicals | 0.96 | 0.39 |
Fertilizers & Agrochemicals | 1.03 | 0.83 |
Insurance | 1.2 | 2.14 |
Retailing | - | 0.66 |
Top Comparisons
ICICI Prudential Smallcap Fund - Growth
3Y Returns16.16%
Sundaram Small Cap Fund Regular Plan - Growth
3Y Returns16.76%
DSP Global Innovation Fund of Fund - Regular - Growth
3Y Returns0%
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
3Y Returns20.2%
Nippon India Ultra Short Duration Fund- Growth Option
3Y Returns6.25%
INVESCO INDIA ULTRA SHORT DURATION FUND - Growth
3Y Returns6.21%
KOTAK NIFTY AAA BOND JUN 2025 HTM INDEX FUND REGULAR PLAN GROWTH
3Y Returns0%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Regular Plan - Growth
3Y Returns18.42%